MAY 18, 2018 04:29 PM PDT
Likely Cause of Polycystic Ovarian Syndrome ID'ed
WRITTEN BY: Carmen Leitch
2 6 370

Polycystic ovary syndrome (PCOS) is a leading cause of infertility in women and can be a cause of miscarriage. Now research has identified a possible cause of this disorder, which has been unknown. Scientists from the French National Institute of Health and Medical Research have found that overexposure to a molecule called anti-Mullerian hormone, or AMH, leads to PCOS in a mouse model. The work has been reported in Nature Medicine and is briefly outlined in the video.

In women affected by PCOS, multiple cysts grow on the ovaries; they have irregular periods and might have trouble getting pregnant. It is found in women that also have high levels of male hormones, which can lead to excess hair growth on the body and face. 

The treatments for the disease have a host of nasty side effects; there are risks for cardiovascular disease, type 2 diabetes, and infertility. 

The scientists posited that when a fetus is exposed to high levels of AMH, it disrupts signals coming from the GnRH receptor. That leads to the symptoms seen in PCOS, and also presents a new therapeutic target for drug development.

The image shows a mouse ovary with proteins specific to oocytes labelled in red and yellow. / Credit: Schimenti Lab, Cornell University

The investigators found that pregnant women that have PCOS also have levels of AMH that are 30 percent higher than they should be. The disorder tends to cluster in families, so the researchers thought that the hormone might have something to do with the development of the disorder.

They used pregnant mice to show that fetuses that are exposed to high levels of AMH will develop PCOS. The mice in their study had a delayed onset of puberty, ovulated infrequently, got pregnant later and had fewer pups than unaffected mice, which are all signs of the disorder.

Intriguingly, the scientists were able to reverse the symptoms of the disease in mice when they used the drug cetrorelix, an IVF medication.

"It could be an attractive strategy to restore ovulation and eventually increase the pregnancy rate in these women," commented lead author Dr. Paolo Giacobini, to New Scientist.

The researchers think this may be why finding a genetic cause for PCOS has been so elusive. They also hope to begin drug trials by the end of the year to test its efficacy in people.

Sources: New Scientist, Mayo Clinic, Nature Medicine

About the Author
  • Experienced research scientist and technical expert...
You May Also Like
MAY 04, 2018
Clinical & Molecular DX
MAY 04, 2018
New Blood Test Detects Peanut Allergy with 98% Specificity
A new blood test trumps traditional diagnostic methods for determining peanut allergy, the most common allergy for children. From the Medical Research Coun
MAY 27, 2018
Cell & Molecular Biology
MAY 27, 2018
Why Opioids Can't Always Reduce Chronic Pain
While opioids have been in use in North America since at least the time of the Civil War, we still don't know everything about them.
JUN 05, 2018
Cancer
JUN 05, 2018
Precision vs. Personalized Medicine Part II: Personalized Approach
So often the phrases "Precision Medicine" and "Personalized Medicine" are used interchangeably. Are they really synonyms? Part II looks at Personalized Medicine
JUN 12, 2018
Cancer
JUN 12, 2018
CD44 Insights & Cancer Influence
CD44 is a known cell surface protein involved in numerous interactions; it is overexpressed in cancerous tissue and its isoforms are being investigated as targets for cancer immunotherapy
JUN 16, 2018
Clinical & Molecular DX
JUN 16, 2018
Nanoparticles Deliver "Theranostics" for Cancer Patients
New technology combing therapeutic agents and diagnostics (theranostics) can be used to deliver drugs to cancer cells. From the Moscow Institute of Physics
JUN 20, 2018
Cell & Molecular Biology
JUN 20, 2018
Some Cells can Suppress Fat Formation
Scientists discovered a new kind of human cell that interferes with the creation of fat cells.
Loading Comments...